4
Changes in Ownership
Fulcrum Therapeutics, Inc. Filed Acc 0000899243-22-021530
Director sold 71,435 shares at $8.09 ($577,895)
- Director acquired 71,435 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Gould Robert J · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-06-07 | Exercise or conversion : show line 1 in the form | +71,435 | $7.84 | $560,050 | 578,065 | D |
| 2022-06-07 | Sale : show line 2 in the form | −71,435 | $8.09 | $577,895 | 506,630 | D |
| Open-market sales · 71,435 sh · avg $8.09 · $577,895 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-06-07 | Exercise or conversion : show line 3 in the form Stock Option (right to buy) | −71,435 | 86,523 | D |
Loading xslF345X03/doc4.xml…